PHA-739358 for the Treatment of Multiple Myeloma

Mise à jour : Il y a 4 ans
Référence : NCT00872300

Femme et Homme

Extrait

The purpose of this study is to determine the antitumor activity of PHA-739358 as single agent IV infusion in adult patients with Multiple Myeloma who have a history of at least 2 previous lines of treatment for the disease.


Critère d'inclusion

  • Multiple myeloma

Liens